Publications

Enhancing the longevity and in vivo potency of therapeutic proteins: The power of CTP

Doron Calo, et al. Precis Med 2015; 2: e989. doi: 10.14800/pm.989

Pharmacokinetics, Pharmacodynamics, and Safety of a Long-Acting Human Growth Hormone (MOD-4023) in Healthy Japanese and Caucasian Adults

Clinical Pharmacology in Drug Development 2017, 00(0) 1–10, Copyright 2017 The Authors. Clinical Pharmacology in Drug Development, published by Wiley Periodicals, Inc. on behalf of The American College of Clinical Pharmacology, DOI: 10.1002/cpdd.414

MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults

European Journal of Endocrinology, C J Strasburger and others, Phase 2 study of MOD-4023 in GHD adults, 176:3, 283–294, DOI: 10.1530/EJE-16-0748

Long-Acting CTP-Modified hGH (MOD-4023): Results of a Safety and Dose-Finding Study in GHD Children

The Journal of Clinical Endocrinology & Metabolism; DOI: 10.1210/jc.2016-3547

Clinical Validation Studies of the 4Kscore

4Kscore as a Predictor of Prostate Cancer Metastases and Prostate Cancer Mortality

4Kscore: Its Clinical Use to Reduce Prostate Biopsies and Reduce Healthcare Costs

NCCN® Prostate Cancer Early Detection Guidelines

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)

Prostate Cancer Early Detection, Version 1.2018. Accessed March 20, 2018.

Iron-magnesium hydroxycarbonate (fermagate): a novel non-calcium-containing phosphate binder for the treatment of hyperphosphatemia in chronic hemodialysis patients.

McIntyre CW, Pai P, Warwick G, Wilkie M, Toft AJ, Hutchison AJ. Clin J Am Soc Nephrol. 2009 Feb;4(2):401-9. doi: 10.2215/CJN.02630608. Epub 2009 Jan 21.